Skip to main content
Erschienen in: The European Journal of Health Economics 2/2010

01.04.2010 | Original Paper

A social preference valuations set for EQ-5D health states in Flanders, Belgium

verfasst von: Irina Cleemput

Erschienen in: The European Journal of Health Economics | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

This study aimed at deriving a preference valuation set for EQ-5D health states from the general Flemish public in Belgium. A EuroQol valuation instrument with 16 health states to be valued on a visual analogue scale was sent to a random sample of 2,754 adults. The initial response rate was 35%. Eventually, 548 (20%) respondents provided useable valuations for modeling. Valuations for 245 health states were modeled using a random effects model. The selection of the model was based on two criteria: health state valuations must be consistent, and the difference with the directly observed valuations must be small. A model including a value decrement if any health dimension of the EQ-5D is on the worst level was selected to construct the social health state valuation set. A comparison with health state valuations from other countries showed similarities, especially with those from New Zealand. The use of a single preference valuation set across different health economic evaluations within a country is highly preferable to increase their usability for policy makers. This study contributes to the standardization of outcome measurement in economic evaluations in Belgium.
Literatur
1.
Zurück zum Zitat Dolan, P.: Modeling valuations for EuroQol health states. Med Care 35, 1095–1108 (1997)CrossRef Dolan, P.: Modeling valuations for EuroQol health states. Med Care 35, 1095–1108 (1997)CrossRef
2.
Zurück zum Zitat MVH Group: The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics (1995) MVH Group: The measurement and valuation of health. Final report on the modelling of valuation tariffs. York Centre for Health Economics (1995)
3.
Zurück zum Zitat Greiner, W., Claes, C., van Busschbach, J., Graf von der Schulenburg, J.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6, 124–130 (2005)CrossRef Greiner, W., Claes, C., van Busschbach, J., Graf von der Schulenburg, J.: Validating the EQ-5D with time trade off for the German population. Eur J Health Econ 6, 124–130 (2005)CrossRef
4.
Zurück zum Zitat Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 11, 341–353 (2002)CrossRef Tsuchiya, A., Ikeda, S., Ikegami, N., Nishimura, S., Sakai, I., Fukuda, T., Hamashima, C., Hisashige, A., Tamura, M.: Estimating an EQ-5D population value set: the case of Japan. Health Econ 11, 341–353 (2002)CrossRef
5.
Zurück zum Zitat Wittrup-Jensen, K.U., Lauridsen, J.T., Gudex, C., Brooks, R., Pedersen, K.M.: Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder, A., Pedersen, K., Roos, P. (eds.) 18th Plenary Meeting of the EuroQol Group, pp. 257–92. IHE, The Swedish Institute for Health Economics (2002) Wittrup-Jensen, K.U., Lauridsen, J.T., Gudex, C., Brooks, R., Pedersen, K.M.: Estimating Danish EQ-5D tariffs using TTO and VAS. In: Norinder, A., Pedersen, K., Roos, P. (eds.) 18th Plenary Meeting of the EuroQol Group, pp. 257–92. IHE, The Swedish Institute for Health Economics (2002)
6.
Zurück zum Zitat Lamers, L.M., McDonnell, J., Stalmeier, P., Krabbe, P., Busschbach, J.: The Dutch Tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 15, 1121–1132 (2006)CrossRef Lamers, L.M., McDonnell, J., Stalmeier, P., Krabbe, P., Busschbach, J.: The Dutch Tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ 15, 1121–1132 (2006)CrossRef
7.
Zurück zum Zitat Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43, 203–220 (2005)CrossRef Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43, 203–220 (2005)CrossRef
8.
Zurück zum Zitat Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul Health Metrics 1, 11 (2003)CrossRef Jelsma, J., Hansen, K., De Weerdt, W., De Cock, P., Kind, P.: How do Zimbabweans value health states? Popul Health Metrics 1, 11 (2003)CrossRef
9.
Zurück zum Zitat Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21, 7–16 (2001)CrossRef Badia, X., Roset, M., Herdman, M., Kind, P.: A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making 21, 7–16 (2001)CrossRef
10.
Zurück zum Zitat Claes, C., Greiner, W., Uber, A., Graf von der Schulenburg, J.: An interview-based comparison of the TTO and VAS values given to EuroQol states of health by the general German population. In: Greiner, W., Graf von der Schulenburg, J., Piercy, J. (eds.) EQ Plenary Meeting. Hannover (1999) Claes, C., Greiner, W., Uber, A., Graf von der Schulenburg, J.: An interview-based comparison of the TTO and VAS values given to EuroQol states of health by the general German population. In: Greiner, W., Graf von der Schulenburg, J., Piercy, J. (eds.) EQ Plenary Meeting. Hannover (1999)
11.
Zurück zum Zitat Ohinmaa, A., Eija, H., Sintonen, H.: Modelling EuroQol values of Finnish adult population. In: Badia, X., Herdman, M., Segura, A., (eds.) EuroQol Plenary Meeting. Barcelona. Institut Universitari de Salut Publica de Catalunya (1995) Ohinmaa, A., Eija, H., Sintonen, H.: Modelling EuroQol values of Finnish adult population. In: Badia, X., Herdman, M., Segura, A., (eds.) EuroQol Plenary Meeting. Barcelona. Institut Universitari de Salut Publica de Catalunya (1995)
12.
Zurück zum Zitat Ohinmaa, A., Sintonen, H.: Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. Paper presented tot the 15th EuroQol Plenary Meeting, Hanover (1998) Ohinmaa, A., Sintonen, H.: Inconsistencies and modelling of the Finnish EuroQol (EQ-5D) preference values. Paper presented tot the 15th EuroQol Plenary Meeting, Hanover (1998)
13.
Zurück zum Zitat Devlin, N.J., Hansen, P., Kind, P., Williams, A.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ 12, 529–544 (2003)CrossRef Devlin, N.J., Hansen, P., Kind, P., Williams, A.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ 12, 529–544 (2003)CrossRef
14.
Zurück zum Zitat Prevolnik Rupel, V., Rebolj, M.: The Slovenian VAS Tariff based on valuations of EQ-5D health states from the general population. In: Cabasés, J.M., Gaminde, I. (eds.) 17th Plenary Meeting of the EuroQol Group, pp. 23–47. Universidad Pública de Navarra (2001) Prevolnik Rupel, V., Rebolj, M.: The Slovenian VAS Tariff based on valuations of EQ-5D health states from the general population. In: Cabasés, J.M., Gaminde, I. (eds.) 17th Plenary Meeting of the EuroQol Group, pp. 23–47. Universidad Pública de Navarra (2001)
15.
Zurück zum Zitat Badia, X., Roset, M., Monserrat, S., Herdman, M.: The Spanish VAS tariff based on valuations of EQ-5D health states from the general population. Proceedings of the EuroQol Plenary Meeting, Rotterdam (1997) Badia, X., Roset, M., Monserrat, S., Herdman, M.: The Spanish VAS tariff based on valuations of EQ-5D health states from the general population. Proceedings of the EuroQol Plenary Meeting, Rotterdam (1997)
16.
Zurück zum Zitat Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., de Charro, F.: A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4, 222–231 (2003)CrossRef Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., de Charro, F.: A single European currency for EQ-5D health states. Results from a six-country study. Eur J Health Econ 4, 222–231 (2003)CrossRef
17.
Zurück zum Zitat Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets: inventory. Comparative Review and User Guide. Springer, Dordrecht (2007)CrossRef Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets: inventory. Comparative Review and User Guide. Springer, Dordrecht (2007)CrossRef
18.
Zurück zum Zitat Gudex, C., Dolan, P., Kind, P., Williams, A.: Health state valuations from the general public using the visual analogue scale. Qual Life Res 5, 521–531 (1996)CrossRef Gudex, C., Dolan, P., Kind, P., Williams, A.: Health state valuations from the general public using the visual analogue scale. Qual Life Res 5, 521–531 (1996)CrossRef
19.
Zurück zum Zitat Nord, E.: EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18, 25–36 (1991)CrossRef Nord, E.: EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 18, 25–36 (1991)CrossRef
20.
Zurück zum Zitat Brooks, R., Jendteg, S., Lindgren, B., Persson, U., Björk, S.: EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 18, 37–48 (1991)CrossRef Brooks, R., Jendteg, S., Lindgren, B., Persson, U., Björk, S.: EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 18, 37–48 (1991)CrossRef
21.
Zurück zum Zitat van Agt, H.M., Essink-Bot, M.L., Krabbe, P.F., Bonsel, G.J.: Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1982) 39, 1537–1544 (1994) van Agt, H.M., Essink-Bot, M.L., Krabbe, P.F., Bonsel, G.J.: Test–retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1982) 39, 1537–1544 (1994)
22.
Zurück zum Zitat Badia, X., Fernandez, E., Segura, A.: Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Pub Health 5, 87–93 (1995)CrossRef Badia, X., Fernandez, E., Segura, A.: Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Pub Health 5, 87–93 (1995)CrossRef
23.
Zurück zum Zitat Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316, 736–741 (1998) Kind, P., Dolan, P., Gudex, C., Williams, A.: Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J 316, 736–741 (1998)
24.
Zurück zum Zitat Dolan, P., Kind, P.: Inconsistency and health state valuations. Soc Sci Med 42, 609–615 (1996)CrossRef Dolan, P., Kind, P.: Inconsistency and health state valuations. Soc Sci Med 42, 609–615 (1996)CrossRef
25.
Zurück zum Zitat O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5–389 (1994) O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. PharmacoEconomics 5–389 (1994)
26.
Zurück zum Zitat Gudex, C., Dolan, P.: Valuing health states: the effect of duration. Discussion Paper (1995) Gudex, C., Dolan, P.: Valuing health states: the effect of duration. Discussion Paper (1995)
27.
Zurück zum Zitat Dolan, P.: The effect of experience of illness on health state valuations. J Clin Epidemiol 49, 551–564 (1996)CrossRef Dolan, P.: The effect of experience of illness on health state valuations. J Clin Epidemiol 49, 551–564 (1996)CrossRef
28.
Zurück zum Zitat Badia, X., Monserrat, S., Roset, M., Herdman, M.: Feasibility, validity and test–retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 8, 303–310 (1999)CrossRef Badia, X., Monserrat, S., Roset, M., Herdman, M.: Feasibility, validity and test–retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off. Qual Life Res 8, 303–310 (1999)CrossRef
29.
Zurück zum Zitat Cleemput, I., Van Wilder, P., Vrijens, F., Huybrechts, M., Ramaekers, D.: Guidelines for Pharmacoeconomic Evaluations in Belgium. KCE Reports. Belgian Health Care Knowledge Centre (KCE), Bruxelles (2008) Cleemput, I., Van Wilder, P., Vrijens, F., Huybrechts, M., Ramaekers, D.: Guidelines for Pharmacoeconomic Evaluations in Belgium. KCE Reports. Belgian Health Care Knowledge Centre (KCE), Bruxelles (2008)
30.
Zurück zum Zitat Cleemput, I., van Wilder, P., Huybrechts, M., Vrijens, F.: Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value Health 2008; Early View (2008) Cleemput, I., van Wilder, P., Huybrechts, M., Vrijens, F.: Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests. Value Health 2008; Early View (2008)
Metadaten
Titel
A social preference valuations set for EQ-5D health states in Flanders, Belgium
verfasst von
Irina Cleemput
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
The European Journal of Health Economics / Ausgabe 2/2010
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-009-0167-0

Weitere Artikel der Ausgabe 2/2010

The European Journal of Health Economics 2/2010 Zur Ausgabe